MARC 닫기

• LDR

  00000cam c2200205 c 4500

• 001

  000000587757

• 005

  20200901141223

• 006

  m d

• 007

  cr cnu|||unuuu

• 008

  180403s2019 maua o 001 engd

• 019

  ▼a  1030600722
  ▼a  1030768607

• 020

  ▼a  9781284149838
  ▼q  (electronic bk.)

• 020

  ▼a  1284149838
  ▼q  (electronic bk.)

• 020

  ▼z  9781284149821

• 020

  ▼z  128414982X

• 035

  ▼a  1743646
  ▼b  (N$T)

• 035

  ▼a  (OCoLC)1030303786
  ▼z  (OCoLC)1030600722
  ▼z  (OCoLC)1030768607

• 040

  ▼a  N$T
  ▼b  eng
  ▼c  N$T
  ▼d  EBLCP
  ▼d  248023
  ▼d  YDX
  ▼d  N$T
  ▼e  rda
  ▼e  pn

• 050

  ▼a  RC280.M37

• 082

  ▼a  616.9941
  ▼2  23

• 100

  ▼a  Gasparetto, Christina,
  ▼e  author.

• 245

  ▼a  Understanding multiple myeloma
  ▼h  [electronic resource]/
  ▼d  Christina Gasparetto, MD, Associate Professor of Medicine, Director Multiple Myeloma Program, Duke University Medical Center, Dharshan Sivaraj, Duke University.

• 260

  ▼a  Burlington, MA:
  ▼b  Jones & Bartlett Learning,
  ▼c  [2019].

• 300

  ▼a  1 online resource:
  ▼b  illustrations.

• 336

  ▼a  text
  ▼b  txt
  ▼2  rdacontent

• 337

  ▼a  computer
  ▼b  c
  ▼2  rdamedia

• 338

  ▼a  online resource
  ▼b  cr
  ▼2  rdacarrier

• 500

  ▼a  Includes index.

• 505

  ▼a  Multiple Myeloma Staging SystemsPrognostic Factors in Multiple Myeloma; Chapter 4 Response Assessment and Introduction to Treatment; Assessment of Response; Clinical Trials; Chemotherapy; Steroids; Interferon-a; Arsenic Trioxide; Radiotherapy; Immunomodulatory Agents; Proteasome Inhibitors; Histone Deacetylase Inhibitors; Monoclonal Antibodies; Treatment Overview; Chapter 5 High-Dose Chemotherapy and Stem Cell Transplant; Introduction to Blood and Marrow Transplants; Steps in an Autologous Stem Cell Transplant; Risks and Potential Side Effects of Autologous Transplant

• 505

  ▼a  Intro; Title Page; Copyright Page; Dedication; Contents; Preface; Acknowledgements; Chapter 1 Who Gets Multiple Myeloma?; Chapter 2 What Is Multiple Myeloma?; History of Multiple Myeloma; Immunoglobulins (Antibodies); Plasma Cells; Myeloma Pathogenesis; The Bone Marrow Microenvironment; Tumor Angiogenesis; Bone Destruction in Multiple Myeloma; Drug Resistance; Chapter 3 Diagnosis and Staging of Multiple Myeloma; Diagnostic Criteria and Classification of Multiple Myeloma; Clinical Symptoms and Signs of Multiple Myeloma; Investigational Studies of Multiple Myeloma

• 505

  ▼a  How to Improve Autologous Stem Cell Transplant OutcomesAllogeneic Stem Cell Transplants; Summary; Chapter 6 Supportive Care; Anemia; Fatigue; Pain Management; Bone Destruction; Treatment of Elevated Calcium (Hypercalcemia); Bisphosphonate Therapy; RANK Ligand (RANKL) Inhibition; Treatment of Bone Fractures; Peripheral Neuropathy; Infections; Hyperviscosity Syndrome; Role of Diet and Exercise; Summary; Chapter 7 Searching for the Cure; Introduction; Angiogenesis Inhibitors; Inhibitors of Myeloma Growth Processes; Agents that Affect Apoptosis; Immune Therapies and Vaccinations

• 588

  ▼a  Print version record.

• 650

  ▼a  Multiple myeloma.

• 655

  ▼a  Electronic books.

• 700

  ▼a  Sivaraj, Dharshan,
  ▼e  author.

• 776

  ▼c  Original,
  ▼z  128414982X,
  ▼z  9781284149821
  ▼w  (OCoLC)1002483310

• 776

  ▼i  Print version:
  ▼a  Gasparetto, Christina.
  ▼t  Understanding multiple myeloma.
  ▼d  Burlington, MA : Jones & Bartlett Learning, [2019],
  ▼z  9781284149821
  ▼w  (OCoLC)1031107014

• 856

  ▼3  EBSCOhost
  ▼u  http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1743646

• 990

  ▼a  강리원